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Abstract
Background
Alteration of functional regenerative properties of parenchymal lung fibroblasts is widely
proposed as a pathogenic mechanism for chronic obstructive pulmonary disease (COPD).
However, what these functions are and how they are impaired in COPD remain poorly un-
derstood. Apart from the role of fibroblasts in producing extracellular matrix, recent studies
in organs different from the lung suggest that such cells might contribute to repair processes
by acting like mesenchymal stem cells. In addition, several reports sustain that the Hedge-
hog pathway is altered in COPD patients thus aggravating the disease. Nevertheless,
whether this pathway is dysregulated in COPD fibroblasts remains unknown.
Objectives and Methods
We investigated the stem cell features and the expression of Hedgehog components in
human lung fibroblasts isolated from histologically-normal parenchymal tissue from 25 pa-
tients—8 non-smokers/non-COPD, 8 smokers-non COPD and 9 smokers with COPD—
who were undergoing surgery for lung tumor resection.
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Results
We found that lung fibroblasts resemble mesenchymal stem cells in terms of cell surface
marker expression, differentiation ability and immunosuppressive potential and that these
properties were altered in lung fibroblasts from smokers and even more in COPD patients.
Furthermore, we showed that some of these phenotypic changes can be explained by an
over activation of the Hedgehog signaling in smoker and COPD fibroblasts.
Conclusions
Our study reveals that lung fibroblasts possess mesenchymal stem cell-features which are
impaired in COPD via the contribution of an abnormal Hedgehog signaling. These process-
es should constitute a novel pathomechanism accounting for disease occurrence
and progression.
Introduction
Chronic obstructive pulmonary disease (COPD) is an incurable disease representing the fourth
leading cause of death worldwide. It is characterized by a heterogeneous collection of condi-
tions associated with chronic expiratory airflow reduction and high risk of lung cancer. Expo-
sure to tobacco smoke is the main cause of COPD and accounts for up to 80% of cases.
However, only around 20% of smokers are at risk for the disease [1]. This observation reflects
differences in effectiveness of lung repair mechanisms between the smokers who develop
COPD in response to smoke-induced injuries and those who do not.
Impairment of functional properties of lung fibroblasts, which are key players in maintain-
ing tissue homeostasis, is believed to be an important mechanism underlying COPD. Several
processes accounting for fibroblast dysfunction have been described such as activation of both
apoptosis and nucleic acid oxidation, inhibition of fibroblast proliferation and fibronectin syn-
thesis, loss of contractile properties, deregulation of soluble factor secretion and senescence [1–
7].
Interestingly, several recent studies conducted in various organs have shown that fibroblasts
share some features with mesenchymal stem cells (MSC). In particular, fibroblasts exhibit cell-
surface expression pattern similar to MSC [8,9], are capable of multilineage differentiation into
adipocytes, osteoblasts and chondrocytes [8,10] and display immunosuppressive properties
[11]. Whether these cells could repair tissue damage through modalities classically attributed
to MSC [10] remains an open question and, although the physiological significance of these
MSC-like features in fibroblasts is still unknown, it is tempting to suggest that alteration of
these properties is involved in the development and/or progression of several degenerative dis-
eases. This hypothesis may also apply to COPD but specific studies comparing lung parenchy-
ma fibroblasts to MSC have never been carried out. An important signaling pathway that could
influence COPD progression or exacerbation is Hedgehog (Hh). In fact, evidences from micro-
array profiling and genome-wide association studies in human subjects and animal models
suggest that this pathway is disturbed in COPD [12]. Hh signaling pathway has been shown to
orchestrate lung organogenesis and plays during the adult life a central role in tissue repair
[13], cancer development [14] and stem cell fate [15–19]. Hh signaling is initiated by the bind-
ing of the Hh ligand to its transmembrane receptor Patched1 (Ptc), relieving suppression of the
transmembrane protein Smoothened (Smo). Smo activates an intracellular cascade that results
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in activation of Gli transcription factors which mediate Hh specific responses in the cell by
modulating gene expression [20]. Intriguingly, two independent studies in COPD patients
have reported a mutation near the locus of Hh interacting protein (Hhip) [21,22], which is a
critical regulator of the Hh pathway [23]. However, whether Hh signaling is dysregulated in fi-
broblasts from COPD patients remains unknown.
Here, we investigated stemness properties and Hh signaling in human adult lung parenchy-
mal fibroblasts from non smokers, smokers and COPD patients.
Material and Methods
Clinical features of lung fibroblast donors
Lung fibroblasts were obtained from 25 patients: 8 non-smokers (C-NS), 8 smokers (C-S) with-
out clinical or functional signs of COPD and 9 smokers with mild and moderate COPD
(COPD) according to the Global Initiative for Chronic Obstructive Lung Disease classification
(http://www.goldcopd.org/). The three groups were closely matched in age and sex and the two
categories of smokers, with or without COPD, had similar smoking history (see clinical features
in Table 1). As expected, patients with COPD showed lung functional alterations, including
significantly lower forced expiratory volume in one sec (FEV1) compared to controls. All
COPD patients had pulmonary emphysema as assessed by CT scan. Histology of lung tumors
was similar among the three groups (data not shown). None of the patients had chronic cardio-
vascular, hepatic or renal disease or had undergone chemotherapy for cancer.
Cell isolation and cell culture conditions
Lung fibroblasts were isolated from lung tissue of patients undergoing resective surgery for pul-
monary carcinoma. After careful macroscopic evaluation, pleura-free parenchymal specimens
were excised from peripheral areas of the lobe as far away from the tumor site as possible. Der-
mal fibroblasts were isolated from healthy donor skin biopsies. Lung and dermal fibroblasts
were obtained by the explant method as previously described [24,25]. Human Multipotent Adi-
pose Derived stem cells (hMADS cells) were used as MSC model, regarding their high capacity
to proliferate and differentiate into several specialized cells. These cells were isolated and ex-
panded as previously reported [26]. Written informed consent was obtained from patients and
Table 1. Subject characteristics.
Non-smokers controls Smokers controls COPD patients p
Patient (no.) 8 8 9
Age (years) 66 (42–80) 59 (51–68) 58 (51–62) NS
Sex (M/F) 3/5 3/5 4/5
FEV1% 99 (87–110) 86 (69–102) $ 70 (57–77 p<0.05
FEV1/VC % 83 (80–100) 78 (71–85) */** 61 (42–69) p<0.01
GOLD classiﬁcation 0/I/II/III/IV 8/0/0/0/0 8/0/0/0/0 0/3/6/0/0
Smoking history 0 56 (23–100) 48 (30–60) NS
Data are expressed as median and minimum and maximum quartiles (in parentheses) $ p<0.05 COPD patients vs. non smokers and smokers
*p<0.05 COPD patients vs. smokers.
** p< 0.01 COPD patients vs. non-smokers.
VC, vital capacity; FEV1, forced expiratory volume in 1 sec; COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive
Lung Disease classiﬁcation
doi:10.1371/journal.pone.0121579.t001
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the study was approved by the “Comité de Protection des Personnes Ile de France IX”. All par-
ticipants provided their written informed consent to participate in this study.
All cell types were cultured in Dulbecco’s modified Eagle’s medium (DMEM), 1 g/L glucose
containing 10% heat-inactivated fetal bovine serum (FBS) (Dominique Dutscher, Brumath,
France), 100 U/ml penicillin, 100 μg/ml streptomycin, and 10 mMHEPES (Invitrogen, Cergy-
Pontoise, France), at 37°C in a 5% CO2 atmosphere.
All experiments were performed using lung fibroblasts at passage 3.
RT-PCR
RNA was extracted with the Quiagen Rneasy Mini Kit (Qiagen, Courtaboeuf, France) and then
reverse-transcribed using the Superscript First-Strand Synthesis System (Invitrogen, Villebon
sur Yvette, France) and Oligo(dT)20. Quantitative RT-PCR reactions were performed in tripli-
cate on a 7900 real-time PCR detection system (Applied Biosystems) using Platinium SYBR
Green qPCR SuperMix (Invitrogen). PCR conditions were 50°C for 2 min, 95°C for 2 min, 45
cycles at 95°C for 15s, and 60°C for 45s, using GAPDH or SF3A1 as the reference gene. Primers
sequences are described in Table 2.
Colony forming unit (CFU) assay, cell proliferation and staining for
senescence-associated β-galactosidase (SA-β-Gal)
For assessment of CFU, cells were plated at a density of 1000 cells in a 60-mm culture dish.
After 14 days, colonies displaying more than 50 cells were counted using Crystal Violet staining
(Sigma-Aldrich). Cumulative population doubling levels (PDLs) and staining for SA-β-Gal ac-
tivity were performed as previously described [24,27].
Table 2. Primer sequences used for qPCR assays.
Human genes Forward Reverse
p16 GGGTCGGGTAGAGGAGGTG CATCATGACCTGGATCGGC
p53 CCTGAGGTTGGCTCTGACTGTA TGTTCCGTCCCAGTAGATTACCA
SF3A1 TGCAGGATAAGACGGAATGGAAACTGA GTAGTAAGCCAGTGAGTTGGAATCTTTG
ALP CTGTGGGCATTGTGACC TGTATTTCCGGCCACC
Osteocalcin CCTTTGTGTCCAAGCAGG CACAGTCCGGATTGAGC
SOX9 GCGGCGGAGGAAGTC TGGGTGGGGTCGGTG
Aggrecan CATTTGCCAGGGGGGGT GGGGTATCTGACGGTC
PPAR γ GCTGAATCCAGAGTCCG GGGGGTGATGTGTTTGAAC
LPL CAGCCTCCGGCTCAG GGAGGCGGTCAGACT
MMP1 CTTGCACTGAGAAAGAAGACAAAGG ACACCCCAGAACAGCAGCA
IGF2 GACACCCTCCAGTTCGTCTG CGGAAACAGCACTCCTCAAC
GLI1 TCCTTACCTCCCAACCTCTGTCTAC GTCCATATAGGGGTTCAGACCACTG
GLI2 GCCTCCGAGAAGCAAGAAGCCAAAA CCTGGTGTCGCATGTCAATCGGTAG
GLI3 CGGGACGGTGTTTGCCATGGAC GGAGGATGGAAGGCAGGGAAAAGAT
PATCHED AAGTATATGCACTGGCAGGAGGAG GTGTGAGACATACTCGTACCCCTTG
SMOTHENED AAGACCTCCTACTTCCACCTGCTC CACGGTATCGGTAGTTCTTGTAGCC
α-SMA GAAGAGCATCCCACCCTGC ATTTTCTCCCGGTTGGCCT
GAPDH GCTCTCTGCTCCTCCTGTTC ACTCCGACCTTCACCTTCC
doi:10.1371/journal.pone.0121579.t002
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Flow cytometry antibodies
Phycoerythrin (PE)-conjugated mouse monoclonal antibodies against human CD117 (clone
YB5.B8), CD34 (clone581/CD34), CD45 (clone TU116), CD90 (clone 5E10), CD133 (clone
170411), CD166 (clone 3A6), VEGF-R (clone 89106), CD13 (clone WM15), HLA I (clone
G46-2.6), CD15(clone H198), HLA-DR (clone G46-6) and CD44 (clone G44-26) and isotype
controls were from R&D Systems (Lille, France) and PE-conjugated CD105 (clone 166707)
was from BD Biosciences (Erembodegem, Belgium). Primary unconjugated STRO-1 (clone
STRO-1) and secondary fluorescein isothiocyanate (FITC)-goat anti-mouse IgG/IgM antibod-
ies were from R&D Systems and BD Biosciences, respectively. Antibodies were used at the con-
centration recommended by the manufacturers.
Cell plasticity
For myofibroblast differentiation, lung fibroblasts were treated with 10 ng/ml TGFβ1 for 3, 4
and 5 days in presence of culture medium containing 1% FBS, prior to staining with a mouse
monoclonal antibody against α-smooth muscle actin (α-SMA) (clone 1A4, 1:200, Sigma-Al-
drich, Saint-Quentin Fallavier, France) followed by a rhodamine-conjugated secondary anti-
body (Invitrogen, Saint Aubin, France). Differentiation into adipocytes and osteoblasts was
performed as previously described [26]. Chondrogenic differentiation was carried out using
Mesenchymal Stem Cell Chondrogenic Differentiation Medium (PromoCell, Heidelberg,
Germany).
Assessment of lung fibroblast paracrine action on peripheral blood
monocyte cells (PBMC) proliferation
105 peripheral blood monocyte cells (PBMC) from healthy consenting donors were stimulated
with phytohemagglutinin (PHA, 1μg/ml, Invitrogen) and exposed to supernatant of 24-hours
cultured cells initially seeded at 4.104cells/ml. After 4 days-exposure, PBMC were overnight ex-
posed to 1μCi 3H-thymidine (Perkin-Elmer, Groningen, The Netherlands) prior to measure in-
corporated radioactivity (TopCount, Perkin-Elmer, Meriden, CT, USA).
In other experiments, 105 PBMC were stimulated with anti-CD3 (clone UCHT1, 2μg/ml,
Beckman Coulter, Villepinte, France) and anti-CD28 (clone CD28.2, 2μg/ml, Beckman Coul-
ter) antibodies and labeled with CFSE (1μM, Invitrogen). Stimulated PBMC were then exposed
to supernatants collected from fibroblasts. After 4 days, the decrease in CFSE fluorescence as-
sessed by flow cytometry was used to determine PBMC proliferation.
Treatment with Hedgehog pathway modulators
Prior to differentiation, flow cytometry and immunosuppressive assays, fibroblasts were treat-
ed for 48 hours with 10μMCyclopamine (LC Laboratories, MA, France), 100nM SAG (Merck
Millipore), 5 μMGant 61 (Merck Millipore) or 5μM Purmorphamine (Enzo Life Sciences, Vil-
leurbanne, France). The concentrations of Hh signaling modulators and the treatment dura-
tion have been optimized on NIH3T3 fibroblasts in previous studies [28,29]. At these
concentrations, drugs were found not cytotoxic as assessed by MTT assay (data not shown). As
drugs were solubilized in DMSO, control cells were incubated with equivalent DMSO volumes.
Immunoblot analysis
Western blotting was performed using standard techniques. Polyclonal anti-human Patched,
anti-human Smo and anti-Shh were generously provided by Dr. Martial Ruat (CNRS-UPR
9040, Gif sur Yvette, France) and used at 1/1000 [28,29]. Rabbit polyclonal anti-human Gli1
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(C68H3, 1/1000) was purchased from Cell Signaling Technology [30] and monoclonal anti-β
tubulin clone TUB 2.1 (1/1000) from SIGMA. Anti-mouse (1/5000) and anti-rabbit (1/2000)
horseradish peroxidase conjugated secondary-antibodies came from Dako. Detection was car-
ried out with an ECL kit (Millipore) and a Las3000 imager (Fugi). Patched, Gli1, ShhN, Smo
and β-tubulin signals were quantified using Image J software and the intensities of Patched,
Gli1, ShhN and Smo signals were corrected for the loading variations using the β-tubulin sig-
nals for each patient. Histograms represent the mean Patched, Gli1, ShhN or Smo signal inten-
sity for each patient group from at least 3 independent experiments.
Primary cilia immunodetection
Primary cilia detection in cultured lung fibroblast was performed as previously described [31–
33]. Briefly, fibroblasts were grown to confluence and then switched to medium containing 1%
FBS for 48 h. Then, cells were fixed with 4% of paraformaldehyde and permeabilized with
0.05% Triton x-100 (Sigma, Saint Quentin Fallavier, France) prior to be with a mouse anti-acet-
ylated tubulin (1:1000, Sigma Aldrich) primary antibodies, overnight at 4°C. Fluorescence sig-
nal was detected by using a goat anti- mouse secondary antibody (1:500, conjugated with Alexa
594, Invitrogen, Cergy-Pontoise, France). The slides were mounted by using prolong DAPI
(Invitrogen, Cergy-Pontoise, France) and examined with a fluorescence microscope coupled to
a digital camera utilizing axiovision software for image acquisition (Zeiss, Jena, Germany).
Statistical analysis
Data were analyzed with GraphPad Prism 4.0 (La Jolla, CA, USA) and expressed as
mean ± SEM. Comparisons between groups were performed with Kruskall–Wallis’ non-
parametric analysis of variance test followed by two-by-two comparisons with Mann–Whit-
ney’s U test when a difference was detected. Comparisons between cells with drug treatment or
not in each group were performed with paired t test. p< 0.05 was considered statistically
significant.
Results
Basic characteristics of lung primary cultured fibroblasts
Although lung primary cultures from C-NS, C-S and COPD patients exhibited typical fibro-
blast morphology and expressed the fibroblastic marker vimentin (Fig 1A and 1B)), we ensured
that they were not contaminated by other cell types which could interfere with the interpreta-
tion of data. We first examined their colony forming (CFU) ability and their transcriptional ex-
pression of MMP1 and IGF2 to distinguish fibroblasts from lung parenchymal MSC. Indeed,
MSC have been reported to have greater CFU potential [9] and to express lesser amount of
MMP1 but higher level of IGF2 than fibroblasts [34]. Like dermal fibroblasts, lung primary cul-
tures had no or extremely poor ability to form colonies (Fig 1C) and expressed 7 to 9 fold
higher levels of MMP1 transcripts and 135 fold lower levels of IGF2 than control MSC (Fig
1D). Lung primary cultures were also found to be devoid of epithelial and endothelial cells as
revealed by negative immunostaining for pancytokeratin and CD31, respectively and did not
express cancer associated fibroblasts (CAF) markers such as desmin, fibroblast activated pro-
tein α and PDGF receptor β (data not shown) confirming the lack of cancer impact. In addi-
tion, because replicative senescence has been reported to affect stemness features [35], we
analyzed proliferative potential, β-galactosidase activity and expression of senescence markers
such as p16 and p53 in the 3 groups of lung fibroblasts (Fig 1E and 1H). We found that whatev-
er the group, these cells had similar proliferative potential (Fig 1E) and were non senescent (Fig
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Fig 1. Characterization of lung fibroblast primary cultures. (a) Morphology and (b) vimentin staining (red signal) of lung fibroblasts from C-NS, CS and
COPD subjects. Nuclei were counterstained with DAPI (blue signal) Scale bar, 20 μm. (c) CFU assays revealed by crystal violet staining. (d)Relative
quantitative transcriptional expression of MMP1 and IGF2 in lung fibroblasts and DF by reference to MSC. (e) Cumulative population doubling level (PDL)
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1F and 1H). Interestingly and consistent with previous observations [36], we showed that lung
fibroblasts similarly to that of dermis divided faster than did control MSC (Fig 1E). Altogether,
these results indicate that the lung fibroblast primary cultures used in this study were equiva-
lent in terms of purity, proliferation and viability.
Multilineage differentiation potential of lung fibroblasts and their
alteration in smoker controls and COPD patients
Having established that fibroblasts from the three groups of patients displayed similar basic
characteristics, we first examined their ability to acquire an activated “myofibroblast” pheno-
type following treatment with transforming growth factor β1 (TGF-β1) for 3 to 5 days. Staining
of α smooth muscle actin (α-SMA) was used to detect myofibroblasts and an increased number
of positive cells was measured in all cell groups including in control dermal fibroblasts and
MSC from day-3 to day-5 stimulation with TGF-β1 (Fig 2A). Nevertheless, after day-4 and
day-5 TGF-β1 exposure, the rate of differentiation into myofibroblasts was significantly re-
duced in cells obtained from COPD patients (35.3 ± 1.8%, 40.4 ± 6.4% and 20.4 ± 2.4% for
C-NS, C-S and COPD respectively at day 4 and 78.7 ± 0.5%, 80.9 ± 3.6% and 69 ± 2.4% at day
5 (Fig 2A), indicating a defective response towards TGF-β1 by COPD fibroblasts.
To determine whether lung fibroblasts shared the multilineage differentiation potential at-
tributed to MSC, they were placed in adipogenic-, chondrogenic- and osteoblastic-conditioned
media. Staining with Oil red O, alcian blue and alizarin red dyes combined to real time PCR as-
says for the transcriptional expression of lineage specific markers including peroxysome prolif-
erative activated receptor gamma 2 (PPAR-γ2), lipoprotein lipase (LPL), Sox 9, alkaline
phosphatase (ALP) and osteocalcin (OC) indicated that lung fibroblasts from C-NS patients
were able to differentiate into adipocytes (or lipofibroblasts as some cells had spindle shape
morphology), chondrocytes and osteoblasts more efficiently than dermal fibroblasts although
their multilineage potential is significantly lower than that of control MSC (Fig 2B and 2G). In
addition, fibroblasts from C-S or COPD subjects were found to differentiate with similar effi-
ciency into adipocytes and/or lipofibroblasts and chondrocytes than C-NS ones (Fig 2D and
2E). Nevertheless, by comparison to C-NS fibroblasts, the ability to commit into osteoblasts
was significantly diminished in C-S fibroblasts and was almost absent in COPD cells (Fig 2F
and 2G). Overall, these results indicate that C-NS lung fibroblasts are multipotent and that this
plasticity is gradually lost in cells derived from smokers and COPD subjects.
Lung fibroblasts display MSC-like markers that are progressively altered
in smoker non-COPD and COPD patients
In line with observations already reported for MSC [26,37], flow cytometry analysis indicated
that dermal and C-NS lung fibroblasts did not express CD34, CD117, CD45, CD133, CD15
(SSEA-1), VEGF-R2 (Flk-1) and HLA-class II molecules and were positive for HLA-class I an-
tigens, CD44, CD105 and CD166 (Fig 3A). C-NS lung fibroblasts, like dermal fibroblasts, also
expressed CD90 and CD13 but not STRO-1 (Fig 3B). Interestingly, these three latter markers
were differentially expressed in C-S and COPD fibroblasts. Indeed, decreased level of CD90
and increased CD13 and STRO-1 markers were observed in fibroblasts from COPD patients
(Fig 3B and 3C) and similar, but less pronounced phenotypic changes were found in C-S
and (f) senescence-associated β-galactosidase activity (β-SA) of MSC, DF and lung fibroblasts. (g)Quantitative real-time PCR analysis of mRNA expression
of p53 and p16. (h) Protein expression of p53 and p16 byWestern blot analysis. (a-h)Results represent means ± SEM of at least 3 independent experiments
made with the fibroblast primary cultures at passage 3. NS, non significant; MSC, mesenchymal stem cells; DF, dermal fibroblast; C-NS, non-smoker
controls; C-S, smoker controls; COPD, smokers with COPD.
doi:10.1371/journal.pone.0121579.g001
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Fig 2. In vitro plasticity of lung fibroblasts. (a)Rate of lung fibroblast conversion into myofibroblasts after 3, 4 and 5 days exposure to TGF-β1. * p<0.05
compared to untreated cells. # p<0.05 compared to non- smoker (C-NS) and smoker controls (C-S) exposed to TGF-β1 for 4 or 5 days. (b) Oil-red O staining
of, MSC, DF and lung fibroblasts from C-NS, C-S and COPD subjects12 days after exposure to adipogenic differentiation medium. (c)Alcian blue staining of
MSC, DF and lung fibroblasts at day 24 following chondrogenesis initiation. (d,e)(D, E) Comparative real-time PCR analysis of mRNA expression of genes
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fibroblasts (Fig 3B and 3C). These results indicate that C-NS lung fibroblasts share with MSC
the expression of a panel of cell surface markers and that this “immunophenotype” is progres-
sively altered in fibroblasts from non-COPD and COPD smoker subjects.
Immunosuppressive properties of lung fibroblasts are inhibited in
smokers with or without COPD
As MSC can suppress immune reactions through paracrine mechanisms [11], we also investi-
gated this function in lung fibroblasts by measuring the proliferation either PHA- or CD3/
CD28- activated PBMC exposed to fibroblast-derived supernatants. We found that like
supernatants of MSC and dermal fibroblasts, those from C-NS fibroblasts inhibited PBMC pro-
liferation while supernatants from C-S exhibited a mild but not statistically significant immu-
nosuppressive effect and those from COPD patients were significantly ineffective (Fig 4A and
4B).
Aberrant expression of Hh signaling components in non-COPD and
COPD smoker patients
In order to investigate potential mechanisms involved in the alterations of the stemness pheno-
type for fibroblasts derived from C-S and COPD patients, we focused on the Hh signaling path-
way, which has been shown to control stem cell fate. We first measured the transcriptional and
protein expression of components of the Hh pathway in C-NS, C-S and COPD lung fibroblasts
and found that all three groups expressed Patched, Gli1, Sonic Hedgehog (ShhN) and the Hh
transducing receptor Smoothened (Smo). However, higher levels of the Hh target genes
Patched and Gli1 were detected in C-S and COPD fibroblasts compared to cells from C-NS
subjects (Fig 5A and 5B), supporting the idea that Hh signaling is over-activated in C-S and
COPD lung fibroblasts. Moreover, C-S and COPD fibroblasts produced higher amounts of ac-
tivating peptide ShhN (Fig 5A), suggesting that increased ShhN release by C-S and COPD cells
might be responsible for the up-regulation of the Hh pathway. Curiously, and in comparison
with control C-NS fibroblast, the expression of the Hh transducing receptor Smo is enhanced
in C-S fibroblasts but unaffected in COPD fibroblasts. In addition, we showed by immunocyto-
chemistry that primary cilia were present in lung fibroblasts from the 3 groups suggesting that
these cells can respond to SHH (S1 Fig). To investigate Hh signaling mechanisms in fibroblasts
from C-S and COPD patients, we used modulators of the Hh pathway; the Smo agonists name-
ly purmorphamine (PUR) and SAG, the Smo antagonist cyclopamine (CPN) and the Gli1 an-
tagonist Gant61 (G61). While treatment with Smo agonists or antagonists enhanced or
inhibited Gli1 mRNA expression respectively in the 3 groups of fibroblasts, it showed less effect
on Patched mRNA and protein expression from C-S and COPD fibroblasts (Fig 5C and 5D).
Indeed, while treatment with PUR or SAG induced up regulation of Patched in fibroblasts
from 3 C-NS patients over 4, the up regulation of Patched is observed in the fibroblasts of only
1 C-S patient over 5 and 1 COPD patient over 4 (Fig 5D and data not shown). Moreover, CPN
and G61 treatment induced lower down regulation of Patched in fibroblasts from C-S and
COPD patients than in those of C-NS patients (Fig 5C and 5D). Our results show that fibro-
blasts from C-S and COPD patients present an aberrant activation of the Hh pathway.
encoding for (d) adipogenic peroxysome proliferative activated receptor gamma 2 (PPAR-γ 2; early), lipoprotein lipase (LPL; late) and (e)chondrogenic Sox-9
marker. (f) Alizarin red staining of cells following 17 days of osteoblastic induction and (g)real-time PCR analysis of mRNA expression of osteoblastic alkaline
phosphatase (ALP, early) and osteocalcin (OC, late) markers. (d,e,g) Results represent means ± SEM of at least 3 independent experiments performed with
donor fibroblasts. NS: non significant; * p<0.05, ** p<0.01. MSC, mesenchymal stem cells; DF, dermal fibroblast; C-NS, non-smokers controls; C-S,
smoker controls; COPD, smokers with COPD.
doi:10.1371/journal.pone.0121579.g002
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Fig 3. Cell-surface expression of MSC-associated markers. (a) Representative flow cytometry of CD34, CD117, CD45, CD133, CD15, CD166, VEGF-R,
HLA-DR, CD44, CD105 and HLA-I cell-surface markers in mesenchymal stem cells, dermal fibroblasts and lung fibroblasts from non-smoker controls
(C-NS), smoker controls (C-S) and COPD smokers (COPD). The dotted black line represents control immunoglobulin and the red refers to the specific
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However, these fibroblasts seem to be less responsive to the Hh pathway modulators than fi-
broblasts from C-NS patients suggesting that an alternative non canonical Hh signaling inde-
pendent of Smo and/or Gli1 occurs in C-S and COPD cells.
marker. (b)Flow cytometry of CD90, CD13 and STRO-1. The dotted black line represents control immunoglobulins; the red line refers to the specific marker in
non-smoker control fibroblasts (C-NS) and the blue represents smoker control (C-S) or COPD lung fibroblasts. (c) Histograms representing mean
fluorescence variations for CD90, CD13 and STRO-1 between lung fibroblasts from the 3 groups (C-NS: n = 8, C-S: n = 8 and COPD: n = 9). NS, non
significant, * p<0.05.
doi:10.1371/journal.pone.0121579.g003
Fig 4. Immunosuppressive properties of lung fibroblasts. (a) Proliferation of phytohemagglutinin (PHA)-
stimulated PBMC estimated 3H thymidine incorporation after 5-day exposure to supernatants collected from
24-h cultured MSC, DF and lung fibroblasts from C-NS, C-S and COPD subjects. (b) Proliferation of CD3/
CD28 activated PBMC estimated by CFSE staining 4 days after exposure to supernatants collected from
24-h cultured lung fibroblasts. (a, b)NS: non significant, * p<0.05. MSC, mesenchymal stem cells, DF,
dermal fibroblasts; C-NS: non-smokers controls; C-S: smoker controls; COPD: smokers with COPD. Results
are expressed as means ± SEM of at least n = 3 independent experiments made with the 25 patient
fibroblasts.
doi:10.1371/journal.pone.0121579.g004
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Fig 5. Over-activation of Hedgehog signaling pathway in C-S and COPD fibroblasts. (a)Upper panel: a representative western blot showing the protein
expression of Patched, Gli1, ShhN and Smo in C-NS, C-S and COPD lung fibroblasts at molecular weights of approximately 140, 160, 20 and 100 kDa
respectively which correspond to the expected MW of these proteins, β-tubulin was used as a loading control. Lower panel: histograms representing the
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Hh signaling is involved in the alteration of the stem cell phenotype of
non-COPD and COPD smoker lung fibroblasts
The findings described above led us to postulate that a relationship might exist between the
over-activation of the Hh signaling and the alteration in stemness of non-COPD and COPD
smoker fibroblasts. Thus, we initially examined whether pharmacological inhibition or activa-
tion of Hh signaling affected the conversion of fibroblasts into myofibroblasts. Activation of
the Hh pathway with PUR or SAG or its inhibition with CPN did not significantly TGF-β in-
duced- α-SMA expression in C-NS and C-S fibroblasts while treatment with the Hh antagonist
G61 increased the myofibroblastic conversion of these cells, probably through a non specific
action (as this effect was not confirmed by CPN) (Fig 6A and S2 Fig). Conversely, activation or
inhibition of the Hh pathway respectively decreased or increased the myofibroblastic conver-
sion of COPD fibroblasts (Fig 6A and S2 Fig). In addition, we found that ALP transcriptional
expression was inhibited by exposure to PUR or SAG and improved following treatment with
CPN or G61, respectively in C-S and C-NS fibroblasts groups (Fig 6B), suggesting that conver-
sion of fibroblasts into osteoblasts is sensible to Hh-signaling activation in these fibroblasts.
However, these drugs did not statistically affect the osteoblastic differentiation potential of
COPD cells suggesting that in COPD fibroblasts, non canonical Hh signaling predominates or
that the canonical pathway is dysfunctional. On the other hand, we also observed that treat-
ment with PUR improved STRO-1 expression in COPD fibroblasts but these results could not
be confirmed with SAG suggesting that the effects of PUR on STRO-1 in COPD cells could be
an artifact (Fig 6C). In addition, the cell surface expression of the CD90 and CD13 markers in
these cells did not seem affected by these two agonists of the Hh signaling (Fig 6C).
Curiously, treatment with antagonists of the Hh pathway diminished cell surface expression
of CD90, CD13 and STRO-1 in all lung fibroblasts, suggesting that down-regulation of Hh
signaling could pertub lung fibroblasts immunophenotype (Fig 6C). Finally, exposure to pur-
morphamine, cyclopamine and Gant 61 did not significantly affect the paracrine immunosup-
pressive properties of C-S and C-NS fibroblasts while Hh antagonists significantly improved
the ability of COPD cells to inhibit the proliferation of CD3/CD28 stimulated PBMC (Fig 6D).
These results suggest that the Hh pathway controls the immunosuppressive properties of
COPD but not C-NS and C-S fibroblasts, indirectly supporting the hypothesis that the Hh
pathway is dysregulated in COPD cells.
Discussion
The notion that lung fibroblasts play a key role in the development of COPD is now well ac-
cepted and supported by a series of publications describing the reduced capability of fibroblasts
to sustain tissue repair in this disease [3,4]. However, because fibroblasts are generally consid-
ered as structural cells strictly devoted to maintenance of the extracellular matrix, most of the
studies aiming at identifying dysfunction in COPD lung fibroblasts have only focused on these
mean of signal intensity of Patched, Gli1, ShhN or Smo for each patient group from at least 3 independent experiments. Protein expression was reported as
fold of C-NS. (b) Transcriptional expression of Hh signalling pathway components in C-S and COPD lung fibroblasts compared to C-NS cells as assessed by
quantitative real-time PCR analysis. (c)Quantitative real-time PCR analysis showing transcriptional expression of Patched (PTC) and Gli-1 in C-NS, C-S and
COPD lung fibroblasts following exposure to DMSO (CTL), purmorphamine (PUR), SAG, cyclopamine (CPN) or GANT 61 (G61). (d)Upper panel:
representative western blot showing the expression of Patched (Ptc) following 48h-treatment with pumorphamine (PUR), and 48h- or 72h- treatment with
either cyclopamine (CPN) or GANT-61 (G61). β-tubulin was used as a loading control. Lower panel: relative western blot quantification of patched protein
expression in C-NS, C-S and COPD lung fibroblasts following 48hour-exposure to DMSO (CTL), purmorphamine (PUR), cyclopamine (CPN) or GANT 61
(G61). (a, b, c, d)Results are expressed as means ± SEM of at least n = 3 independent experiments performed with at least n = 5 samples per fibroblast
group. (A, B) * p< 0.05, ** p< 0.01, *** p< 0.001 compared to C-NS. (D, E) * p<0.05, ** p<0.01, *** p<0.001 compared to drug untreated CTL. C-NS:
non-smokers controls; C-S: smoker controls; COPD: smokers with COPD.
doi:10.1371/journal.pone.0121579.g005
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regenerative processes. Since fibroblasts from other organs have been shown to possess stem
cells-like properties [8–11](we aimed in the present study to explore whether human lung fi-
broblasts may also display such features and whether COPD affects this phenotype. We further
investigated the Hh pathway as a modulator of fibroblasts ‘stemness’ and as a signaling path-
way that could be targeted by the disease. Thanks to a detailed characterization of parenchymal
lung fibroblasts, our findings provide the first evidence that these cells indeed resemble MSC
for several markers and that these properties are affected by chronic smoking exposure and
COPD. Additionally, we identify Hh signaling as a pathway that is altered by tobacco smoking
and is involved in the modulation of fibroblasts stem-like features. The hypothesis that lung fi-
broblasts could contribute to lung repair by adopting a MSC behavior [38,39] are supported by
several lines of evidence describing that MSC confer protection against emphysema in mice
chronically exposed to cigarette smoking [40] and promote lung repair in a murine model of
bleomycin-induced lung injury [41]. Of interest, exposure to chronic cigarette smoke adversely
affects MSC functions such as differentiation and migration potentials [40,42], indicating a sus-
ceptibility to smoking-induced damage shared by MSC and lung fibroblasts. Although replica-
tive senescence was previously shown to promote loss of stem cell properties in MSC [35], this
phenomenon cannot explain the phenotypic changes observed in our study, as C-S and COPD
fibroblasts did not express senescence-associated markers. In addition, although we isolated fi-
broblasts from lung specimens of patients with cancer, it is unlikely that the phenotypic
changes detected are associated with cancer since: i) controls and COPD patients suffered from
similar cancer histological types; ii) biopsies were harvested at a distance from the tumor and
were verified to be free of malignant cells and iii) primary cultures of lung fibroblasts did not
exhibit CAF markers (data not shown and [7]). As the COPD fibroblasts included in our study
were derived from patients with mild and moderate disease (according to the GOLD criteria),
it would be interesting to determine whether the degree of alteration of stem cell like properties
is more pronounced in fibroblasts from patients with severe COPD.
Our results also point to the idea that the loss in stem-like properties of fibroblasts is a grad-
ual process induced by cigarette smoke that may begin in smokers and becomes more relevant
with the development of COPD. This was particularly evident in the experiments assessing the
differentiation of fibroblasts into osteoblasts, in the alteration of cell surface markers and in the
inhibition of the fibroblast immunosuppressive properties towards PBMC, which were partial-
ly affected in non COPD smokers but considerably more in COPD smokers. The significance
of these modifications in the pathophysiology of COPD is a crucial question that at present we
can only attempt to address. For example, the changes in cell-surface expression we found in
COPD fibroblasts have been previously documented in some MSC populations and were asso-
ciated with decreased regenerative functions or increased tumorigenicity. In particular, the de-
creased positivity of CD90 was correlated with lung fibrogenesis [43] and impaired lung
development [44], as well as loss of immunosuppressive activity [45] and cell-matrix adhesion
Fig 6. Impact of Hh pharmacological modulators on stemness properties of C-NS, C-S and COPD lung fibroblasts. (a) α-SMA immunostaining for
myofibroblast differentiation of TGF-β-treated C-NS, C-S and COPD fibroblasts following incubation with purmorphamine (PUR), SAG, cyclopamine (CPN) or
GANT 61 (G61). ** p<0.01 cells treated with TGFβ versus untreated cells; †p<0.05 cells treated with TGFβ and exposed to drugs versus cells treated with
TGFβ alone; #p<0.05 fibroblasts treated with TGFβ from COPD patients versus from non smokers and smokers patients. (b) Quantitative real-time PCR
analysis of transcriptional expression of alkaline phosphatase (ALP) to evaluate osteoblast differentiation of C-NS, C-S and COPD lung fibroblasts following
exposure to DMSO (CTL), purmorphamine (PUR), SAG, cyclopamine (CPN) or GANT 61 (G61). * p<0.05 compared to CTL. (c)Flow cytometry analysis of
cell surface expression of CD90, CD13 and STRO-1 in C-NS, C-S and COPD lung fibroblasts following exposure to DMSO (CTL), purmorphamine (PUR),
SAG, cyclopamine (CPN) or GANT 61 (G61). * p<0.05 compared to C-NS, C-S and COPD treated with DMSO, respectively, # p<0.05compared to C-NS
treated with DMSO. (d) Inhibitory effects of conditioned media from lung fibroblasts treated with DMSO (CTL), purmorphamine (PUR), cyclopamine (CPN) or
GANT 61 (G61) on CD3/CD28 stimulated PBMC proliferation assessed by decrease of CFSE fluorescence. Results are expressed by reference to the
respective control group. * p< 0.05 compared to CTL and # p<0.05 compared to PUR. (A-D)Results are expressed as means ± SEM of at least n = 3
independent experiments carried out using the 25 fibroblast cultures. C-NS: non-smokers controls; C-S: smoker controls; COPD: smokers with COPD.
doi:10.1371/journal.pone.0121579.g006
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and migration [46]. Furthermore, increased expression of CD13 and STRO-1 was associated
with enhanced malignancy of MSC and emergence of cancer stem cells [47–49]. Furthermore,
the failure in immunosuppressive activity of fibroblasts from smokers and COPD patients
could be the critical factor in aggravating COPD because impaired fibroblast immunoregulato-
ry properties may trigger the destruction of the pulmonary epithelium via chronic inflamma-
tion induced by tobacco smoking[1].
Another interesting observation reported by the present work is the aberrant activation of
the Hh signaling in CS and COPD fibroblasts. Such an activation is probably a response of
lung fibroblats to counteract the deleterious effects of tobacco smoking, as extensive activation
of Hh occurs during repair of injured airway epithelium [13]. However, our observations show-
ing that C-S and COPD lung fibroblasts poorly responded to Smo modulators suggest that ca-
nonical Hh signaling is defective or misregulated which could explain the failure in COPD to
regenerate the lung or that canonical Hh pathway may not be the only Hh signaling mecha-
nism in these cells. Indeed, Hh pathway activity resulting from mutational activation in the Hh
signal transduction mechanism or ligand-independent aberrant signaling activation could be
unresponsive to Smo or Gli1 modulators [50–53]. Despite the very low amount of patients in-
cluded in the present study, our results are consistent with those reported by Domenech and
coworkers (2012) on primary prostate fibroblasts as the authors showed that prostate fibro-
blasts which express Patched receptor did not significantly modified their expression of Gli
and Patched following exposure to Shh ligands during 48 hours, suggesting that non canonical
Hh pathway is activated in these cells.
Finally, our study provides strong evidence that the dysregulation of Hh signaling in C-S
and COPD fibroblasts triggered some stemness alterations including the decreased myofibro-
blast differentiation, the reduced differentiation potential to osteoblastic lineage and the loss of
immunosuppresive properties. Our data are consistent with earlier studies reporting that acti-
vation of Hh signaling inhibits the differentiation of MSC into osteoblast [54,55]. In addition,
Shh has been reported to stimulate the proliferation of CD3/CD28 activated CD4+ T lympho-
cytes, emphasizing that increased release of Shh by COPD fibroblasts might potentiate Hh sig-
naling to local T cells [56] and therefore contribute to the loss of their immune-suppressive
properties. However and strinkingly, our data about myofibroblast differentiation and the im-
pact of Hh signaling activation are in close discrepancy with the current litterature [57,58]. In-
deed, we found that agonists or antagonists of Hh signalling did not affect the TGF-β-induced
myofibroblastic conversion of C-NS and CS fibroblasts. This is probably due to the fact that
TGF-β which was previously reported to activate the non canonical Hh signaling independent-
ly of Patched/Smo axis in lung fibroblasts [59], was used in high concentration in our experi-
ments (10ng/ml instead 1ng/ml), thus bypassing the effects triggered by Hh signaling- agonists
or antagonists. More difficult to explain are the effects observed following activation and inhi-
bition of the Hh pathway in the TGF-β induced myofibroblastic differentiation of COPD fibro-
blasts. Nevertheless although non mechanistically elucidated, these effects reflect that Hh
pathway is seemingly altered in COPD fibroblasts and that the non canonical pathway is likely
predominant in these cells. Notably, our study is the first to report the status of the Hh pathway
in lung fibroblasts as a function of smoking exposure and disease and to establish its relation-
ship with the stem cell properties of fibroblasts. As aberrant activation of Hh signaling has
been shown to be involved in the emergence and the maintenance of cancer stem cells [60], the
immunophenotypic alterations together with the aberrant Hh signaling activation observed in
lung fibroblasts from smokers, particularly those with COPD, may partially explain why chron-
ic exposure to cigarette smoke affects lung regenerative properties and why smokers are more
susceptible to lung cancer. However, future investigations will be needed to determine the
mechanisms leading to Hh signaling dysfunction in non-COPD and COPD smoker lung
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fibroblasts and to fully understand the exact role of this pathway in tobacco-exposed lung and
COPD disease.
In conclusion, our study reveals new intriguing characteristics of lung fibroblasts and a
novel mechanism that might account for COPD initiation and progression. New insights in
this field are expected to offer valuable information for the development of therapies in regen-
erative lung medicine.
Supporting Information
S1 Fig. Detection of primary cilia in C-NS, C-S and COPD lung fibroblasts. Staining with
acetylated tubulin (red signal) showing the presence of primary cilia (arrowhead). Nuclei were
counterstained with DAPI (blue signal). Scale bar 10μm.
(TIF)
S2 Fig. Effects of TGFβ1 and SAG on the conversion of lung fibroblasts to myofibroblasts.
Lung fibroblasts were treated with 10 ng/ml of TGFβ1 in presence of serum (a) or without
serum (b).  p<0.05 compared to untreated cells. # p<0.05 compared to COPD fibroblasts and
non- smoker and smoker controls exposed to TGFβ1 for 3 days.† compared to COPD fibro-
blasts treated with TGFβ1and SAG and COPD fibroblasts exposed to TGFβ1.
(TIF)
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